Arkolith/Insider Trading/LXEO/Form 4

Townsend Richard Nolan

Chief Executive Officer, DirectorLexeo Therapeutics, Inc. (LXEO) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Sell(S)26K$4.48$116K378K
Jun 29, 2026Grant(A)67K—$0404K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001995218-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML